Otonomy, Inc. (OTIC) Financial Statements (2024 and earlier)

Company Profile

Business Address 4796 EXECUTIVE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:53,10062,90077,40087,10097,90073,800
Cash and cash equivalents53,14862,87477,41281,84385,09651,016
Short-term investments    5,25312,78222,813
Other undisclosed cash, cash equivalents, and short-term investments(48)26(12)422(29)
Inventory, net of allowances, customer advances and progress billings      455
Inventory      455
Prepaid expense      2,593
Other undisclosed current assets3,2483,4783,0682,1871,45229
Total current assets:56,34866,37880,46889,28799,35276,877
Noncurrent Assets
Operating lease, right-of-use asset11,89812,30212,69613,07913,36713,724
Property, plant and equipment1,8121,8501,7711,5981,7861,881
Restricted cash and investments702702702702702702
Other noncurrent assets    212212222
Total noncurrent assets:14,41214,85415,16915,59116,06716,529
TOTAL ASSETS:70,76081,23295,637104,878115,41993,406
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,6966,5588,8786,4025,5465,479
Employee-related liabilities2,4321,8373,4502,9372,3401,801
Accounts payable2,1951,4471,0904671,259573
Accrued liabilities3,0693,2744,3382,9981,9473,105
Debt5489191  1,957
Other undisclosed current liabilities3,4143,3893,3643,3403,2843,260
Total current liabilities:11,65810,03812,3339,7428,83010,696
Noncurrent Liabilities
Long-term debt and lease obligation 15,62716,04015,99715,95515,91313,246
Long-term debt, excluding current maturities 15,62716,04015,99715,95515,91313,246
Other undisclosed noncurrent liabilities11,39811,90512,40012,64313,02313,440
Total noncurrent liabilities:27,02527,94528,39728,59828,93626,686
Total liabilities:38,68337,98340,73038,34037,76637,382
Equity
Equity, attributable to parent32,07743,24954,90766,53877,65356,024
Common stock575757575748
Additional paid in capital614,458612,549610,655608,707606,941572,805
Accumulated other comprehensive income     15
Accumulated deficit(582,438)(569,357)(555,805)(542,226)(529,346)(516,834)
Total equity:32,07743,24954,90766,53877,65356,024
TOTAL LIABILITIES AND EQUITY:70,76081,23295,637104,878115,41993,406

Income Statement (P&L) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues     3590
Cost of revenue
(Cost of Goods and Services Sold)
     (140)(230)
Gross profit:     (105)(140)
Operating expenses(12,755)(13,154)(13,172)(12,479)(12,026)(11,703)
Operating loss:(12,755)(13,154)(13,172)(12,479)(12,131)(11,843)
Interest and debt expense(415)(409)(415)(410)(392)(382)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (1,556)   
Loss from continuing operations:(13,170)(13,563)(15,143)(12,889)(12,523)(12,225)
Loss before gain (loss) on sale of properties:(13,170)(13,563)(15,143)(12,889)(12,523)(12,225)
Other undisclosed net income  111,564  15
Net loss:(13,170)(13,552)(13,579)(12,889)(12,523)(12,210)
Other undisclosed net income attributable to parent89  911 
Net loss available to common stockholders, diluted:(13,081)(13,552)(13,579)(12,880)(12,512)(12,210)

Comprehensive Income ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net loss:(13,170)(13,552)(13,579)(12,889)(12,523)(12,210)
Comprehensive loss:(13,170)(13,552)(13,579)(12,889)(12,523)(12,210)
Other undisclosed comprehensive income, net of tax, attributable to parent89  874
Comprehensive loss, net of tax, attributable to parent:(13,081)(13,552)(13,579)(12,881)(12,516)(12,206)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: